1. Home
  2. Analysis
  3. Tyvaso-dpi
  4. Glipizide

Tyvaso dpi and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tyvaso dpi (treprostinil) and Glipizide (glipizide). Common drug interactions include cough among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Tyvaso dpi and Glipizide. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Tyvaso dpi?

Tyvaso dpi has active ingredients of treprostinil. eHealthMe is studying from 3,551 Tyvaso dpi users. Check the latest studies of Tyvaso dpi.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

On Jul, 08, 2026

28 people who take Tyvaso dpi and Glipizide together, and have interactions are studied.

Tyvaso dpi and Glipizide drug interactions.

What are the common drug interactions of Tyvaso Dpi and Glipizide, by gender? *:

female:

  1. Cough
  2. Depression
  3. Drug tolerance decreased
  4. Fall
  5. Internal injury
  6. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  7. Nausea (feeling of having an urge to vomit)
  8. Oropharyngeal pain
  9. Diarrhoea
  10. Dizziness

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Diarrhoea
  3. Headache (pain in head)
  4. Influenza
  5. Dizziness postural
  6. Dysgeusia (disorder of the sense of taste)
  7. Muscular weakness (muscle weakness)
  8. Peripheral swelling
  9. Cardiac disorder
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Tyvaso Dpi and Glipizide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Oropharyngeal pain
  3. Productive cough

50-59:

n/a

60+:

  1. Decreased appetite
  2. Diarrhoea
  3. Dehydration (dryness resulting from the removal of water)
  4. Fatigue (feeling of tiredness)
  5. Hypersomnia (excessive daytime sleepiness (eds))
  6. Rash erythematous (redness of the skin)
  7. Rash pruritic (redness with itching)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Fall
  10. Hip fracture

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 28 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tyvaso dpi and Glipizide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tyvaso dpi and Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tyvaso dpi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tyvaso dpi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil and glipizide (the active ingredients of Tyvaso dpi and Glipizide, respectively), and Tyvaso dpi and Glipizide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.